🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21478Original Research

Mechanism by which luteolin regulates macrophage polarization in the treatment of knee osteoarthritis

ZHAO Canbin¹,ZENG Ping¹,SHI Weiqi¹,LIU Jinfu¹,DING Qiang¹,GUO Liang¹,WANG Weiwei¹,TAO Hongcheng¹,GUO Yafeng¹,QIN Ying¹

First Clinical Medical College, Guangxi University of Chinese Medicine

Read Executive PreviewQuick FAQ
Mechanism by which luteolin regulates macrophage polarization in the treatment of knee osteoarthritis
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1904, Issue 32 • pp. 100-112Citation:ZHAO Canbin et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织工程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • Network pharmacology identified 137 intersection targets of luteolin, macrophage polarization, and knee osteoarthritis, with NF-κB complex enriched in the protein-protein interaction network. • Luteolin inhibits M1 polarization and promotes M2 polarization of RAW264.7 macrophages, shifting the balance toward an anti-inflammatory phenotype. • Mechanistically, luteolin suppresses NF-κB p65/p50 nuclear translocation, promotes IκB-α expression, and inhibits its phosphorylation, thereby modulating the NF-κB signaling pathway. • These findings suggest that luteolin holds potential as a therapeutic agent for knee osteoarthritis by regulating macrophage polarization via the NF-κB pathway.
Sponsored Research Highlight

Abstract

BACKGROUND: The polarization state of macrophages is closely related to the occurrence and development of knee osteoarthritis. Luteolin can regulate the nuclear transcription factor κB (NF-κB) signaling pathway to affect the polarization process of macrophages, but the specific mechanism remains unclear. OBJECTIVE: To investigate the mechanism of luteolin in the treatment of knee osteoarthritis. METHODS: (1) Intersectional targets of luteolin, macrophage polarization, and knee osteoarthritis were screened by network pharmacology, a protein-protein interaction network was constructed, and GO, KEGG enrichment analysis and molecular docking were performed. (2) After knocking out NF-κB p65, RAW264.7 cells were induced to polarize to M1 and M2 types, and flow cytometry was used to detect cell polarization tendency. Different concentrations of luteolin were used to intervene in RAW264.7 cells, and the appropriate concentration of luteolin was screened by CCK-8 method for subsequent experiments. RAW264.7 cells were induced to polarize to M1 and M2 types, and luteolin was added for intervention, and flow cytometry was used to detect cell polarization tendency. RAW264.7 cells were induced to polarize to M1 type, and luteolin was added for intervention. ELISA was used to detect the levels of tumor necrosis factor α, interleukin-6, and interleukin-10 in the cell supernatant, immunofluorescence staining was used to detect the nuclear translocation of NF-κB p65/p50, and western blot was used to detect the expression and phosphorylation of NF-κB p65 and NF-κB inhibitor protein α. RESULTS AND CONCLUSION: (1) A total of 137 intersection genes were screened, of which 135 target genes were involved in the construction of the protein-protein interaction network. GO and KEGG analysis showed that the NF-κB complex was enriched in the protein-protein interaction network. Molecular docking showed that luteolin docked well with NF-κB inhibitor protein α and NF-κB p50/p65 proteins. (2) After NF-κB p65 knockout, the polarization tendency of RAW264.7 cells to M1 type was inhibited, and spontaneous M2 polarization tendency appeared. Luteolin intervention could inhibit the polarization of RAW264.7 cells to M1 type and promote the polarization to M2 type. During the induction of RAW264.7 cells to M1 polarization, luteolin intervention could inhibit the release of pro-inflammatory factors, promote the release of anti-inflammatory factors, inhibit the nuclear translocation of NF-κB p65/p50, promote the expression of NF-κB inhibitor protein α and inhibit its phosphorylation, and inhibit the expression and phosphorylation of NF-κB p65. The results indicate that luteolin can regulate macrophage polarization through the NF-κB signaling pathway and has a potential therapeutic effect on knee osteoarthritis.

1. Introduction

Knee osteoarthritis is a common degenerative disease of the knee joint. In recent years, due to the acceleration of population aging, the number of patients with knee osteoarthritis has been increasing globally. The causes of knee osteoarthritis include internal factors such as aging and obesity, as well as external factors such as trauma and excessive exercise. The pathogenesis of knee osteoarthritis is a complex pathological process, with progressive degeneration of articular cartilage as the core, accompanied by multi-tissue synergistic lesions. Under abnormal mechanical load and stimulation by inflammatory factors such as interleukin-1 and tumor necrosis factor-α, the synthesis and degradation of chondrocytes are imbalanced, and the activity of matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospondin motifs is enhanced, leading to the rupture of type II collagen network, loss of proteoglycan, and the appearance of fissures and erosion on the cartilage surface. Subchondral bone remodeling occurs due to abnormal load transmission, manifesting as osteosclerosis, cystic changes, and marginal osteophyte formation, further aggravating cartilage damage. Chronic synovitis releases inflammatory mediators, which aggravate cartilage degeneration through circulation or direct diffusion, while the concentration of hyaluronic acid in joint fluid decreases, weakening lubrication and protection functions. Therefore, studying the pathogenesis of knee osteoarthritis is of great significance for its prevention and treatment.

Macrophages are widely distributed in the body and are important components of the immune system, playing key roles in inflammatory responses, metabolic homeostasis, and various disease processes. When stimulated by inflammatory factors such as lipopolysaccharide or interferon-γ, macrophages transform into M1 type, secreting a large number of pro-inflammatory cytokines and aggravating the inflammatory response. When stimulated by interleukin-4 or interleukin-13, macrophages transform into M2 type, secreting anti-inflammatory and repair factors, reducing inflammation and promoting tissue repair. The polarization state of macrophages plays an important regulatory role in the occurrence and development of knee osteoarthritis: inhibiting M1 polarization of macrophages in the synovial tissue of the knee can reduce the release of pro-inflammatory factors such as interleukin-6 and tumor necrosis factor-α, thereby reducing the inflammatory response of the synovial tissue and avoiding the progression of knee osteoarthritis.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
ZHAO Canbin, ZENG Ping, SHI Weiqi, LIU Jinfu, DING Qiang, GUO Liang, WANG Weiwei, TAO Hongcheng, GUO Yafeng, QIN Ying (2026). Mechanism by which luteolin regulates macrophage polarization in the treatment of knee osteoarthritis. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21478
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is the role of macrophage polarization in knee osteoarthritis?

Macrophage polarization plays a crucial role in knee osteoarthritis. M1 macrophages secrete pro-inflammatory cytokines that exacerbate inflammation and cartilage degradation, while M2 macrophages produce anti-inflammatory factors that promote tissue repair. Shifting the balance from M1 to M2 polarization is considered a potential therapeutic strategy.

How does luteolin affect macrophage polarization?

Luteolin inhibits M1 polarization and promotes M2 polarization of macrophages. It suppresses the release of pro-inflammatory cytokines and enhances anti-inflammatory cytokine production, partly by modulating the NF-κB signaling pathway.

What is the molecular mechanism of luteolin in treating knee osteoarthritis?

Luteolin regulates macrophage polarization through the NF-κB signaling pathway. It inhibits NF-κB p65/p50 nuclear translocation, promotes IκB-α expression, and inhibits its phosphorylation, thereby reducing the transcription of pro-inflammatory genes and shifting macrophages toward an anti-inflammatory M2 phenotype.

What methods were used in this study?

The study employed network pharmacology to identify intersection targets, protein-protein interaction network construction, GO and KEGG enrichment analysis, molecular docking, and in vitro experiments including gene knockout, flow cytometry, ELISA, immunofluorescence, and western blot.

What are the potential clinical implications of this research?

The findings suggest that luteolin could be developed as a therapeutic agent for knee osteoarthritis by modulating macrophage polarization. However, further preclinical studies and clinical trials are needed to validate its safety and efficacy.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF